Found 73 matching trials
Study of IFN-α Combined With CAR-T Cell Therapy in Relapsed and Refractory Acute Lymphoblastic Leukemia(R/R-ALL)
PHASE2The purpose of this study is to evaluate the safety and efficacy of IFN-α c...
Location
The First Affiliated Hospital of Soochow University
The Changes of Cytokines During Antiviral Therapy
NAPegylated interferon α-2a(Peg-IFN-α) not only inhibit viral replication, bu...
Location
Beijing Ditan hospital,Capital Medical University
Development and Validation of Models to Predict Functional Cure in Patients With CHB After Peg-IFN Based Therapy
N/AHepatitis B virus (HBV) infection is prevalent across the world. Functional...
Location
Qilu hospital of Shandong University
Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis Patients
PHASE2This study evaluates the effect of adding fish oil to Fingolimod on some se...
Location
Multiple Locations
Cemiplimab/Peg-Interferon-α in Advanced CSCC
PHASE1The primary purpose of this research study is to test the safety and possib...
Location
Miami Cancer Institute at Baptist Health, Inc.
Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer
PHASE1The purpose of the study is to compare efficacy of DCVAC/LuCa + chemotherap...
Location
Multiple Locations
Quality of Life and Psychological Well-being in Patients With Malignant Melanoma
NAThe purpose of this study is to analyse the physical and psychological side...
Location
University Medical Center Collogne, Department of Dermatology
Sequential Combination Therapy With PD-1 Antibody and Peg-IFNα in CHB Patients
NAThis is a prospective study to evaluate the safety and efficacy of Sintilim...
Location
the Fifth Medical Center, Chinese PLA General Hospital
Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis
PHASE3We conducted a randomized controlled trial of adjuvant interferon (IFN) the...
Location
National Cancer Institute
Imatinib Mesylate and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia
PHASE2RATIONALE: Imatinib mesylate and interferon alfa may interfere with the gro...
Location
Robert H. Lurie Comprehensive Cancer Center at Northwestern University